Follow the Carasent AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Carasent AB has logged 0 reports. Market capitalisation: €1.6bn. Every trade is openly available.
Analysts rate Carasent AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 34.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Carasent AB is a company focused on the healthcare and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).